Opiate Addiction Remedy Claims Could Face FTC Substantiation Test
This article was originally published in The Rose Sheet
Executive Summary
The Council of Better Business Bureaus' investigative arm asks Opiate Freedom Center for evidence to substantiate ad claims including "Home Remedies for Opiate Withdrawal Symptom Relief" and supplements "developed to naturally replenish depleted nutrients during opiate detox and withdrawal."
You may also be interested in...
Drug Abuse Withdrawal Supplement Marketers Warned, Claims And Sales Continue
FDA and FTC send joint warning letters to 11 US firms about 12 products marketed as unapproved drugs with claims about aiding in the treatment of opioid addiction and withdrawal. FDA also thanks CSPI for suggesting the agencies investigate a scourge of fraudulent drug-abuse withdrawal claims.
Opioid-Withdrawal 'Aids' Warrant Immediate FDA, FTC Action – CSPI
FDA and the Federal Trade Commission should bring immediate enforcement action against marketers of non-kratom dietary supplements promoted as opioid-withdrawal aids, says the Center for Science in the Public Interest in letters to the agency and commission Dec. 8. The nonprofit identified eight supplement products making opioid-withdrawal claims without sufficient science to support the statements.
Trump's Opioid Commission Asks FDA To Boost Post-Market Vigilance
Pharma is criticized for aggressive marketing, but the report also seeks industry help in research on innovative medication.